Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by (90)Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and...

by Pisani, Francesco, Sciuto, Rosa, Dessanti, Maria Laura, Giannarelli, Diana, Kayal, Ramy, Rea, Sandra, Marchesi, Francesco, Marino, Mirella
Published in Exp Hematol Oncol (2015)

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

by Pizzuti, Laura, Krasniqi, Eriseld, Barchiesi, Giacomo, Mazzotta, Marco, Barba, Maddalena, Amodio, Antonella, Massimiani, Gioia, Pelle, Fabio, Kayal, Ramy, Vizza, Enrico, Grassadonia, Antonino, Tomao, Silverio, Venuti, Aldo, Gamucci, Teresa, Marchetti, Paolo, Natoli, Clara, Sanguineti, Giuseppe, Ciliberto, Gennaro, Vici, Patrizia
Published in J Cancer (2019)

Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS...

by Pizzuti, Laura, Krasniqi, Eriseld, Mandoj, Chiara, Marinelli, Daniele, Sergi, Domenico, Capomolla, Elisabetta, Paoletti, Giancarlo, Botti, Claudio, Kayal, Ramy, Ferranti, Francesca Romana, Sperduti, Isabella, Perracchio, Letizia, Sanguineti, Giuseppe, Marchetti, Paolo, Ciliberto, Gennaro, Barchiesi, Giacomo, Mazzotta, Marco, Barba, Maddalena, Conti, Laura, Vici, Patrizia
Published in Cancers (Basel) (2020)

Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients

by Vici, Patrizia, Pizzuti, Laura, Di Lauro, Luigi, Conti, Laura, Mandoj, Chiara, Antenucci, Anna, Digiesi, Giovanna, Sergi, Domenico, Amodio, Antonella, Marchetti, Paolo, Sperati, Francesca, Valle, Mario, Garofalo, Alfredo, Vizza, Enrico, Corrado, Giacomo, Vincenzoni, Cristina, Tomao, Federica, Kayal, Ramy, Marsella, Annalise, Carosi, Mariantonia, Antoniani, Barbara, Giordano, Antonio, Maugeri-Saccà, Marcello, Barba, Maddalena
Published in J Cancer (2016)